The Manufacturing Process for Lisocabtagene Maraleucel (liso-cel) Enables Robust Clearance of Non-T Cell Impurities across B-Cell Malignancies

Teoh, JJ; Charab, W; Van Gunst, K; Cooper, S; Chan, C; Wesner, J; Larson, RP

MOLECULAR THERAPY, 2021; 29 (4): 410

Abstract

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索